You are here: All Products  > Simcere Zaiming Approved to Launch Novel EGFR for Metastatic Colorectal Cancer

Simcere Zaiming Approved to Launch Novel EGFR for Metastatic Colorectal Cancer

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products